New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
11:23 EDTBIIBRoyalty Pharma acquires additional interest in TECFIDERA for $510M
Royalty Pharma announced earlier that it has acquired an additional interest in the earn-out payable to the former shareholders of Fumapharm AG for $510M in cash. The Fumapharm earn-out primarily represents an indirect interest in sales of Biogen Idec's TECFIDERA, an oral therapeutic for the treatment of relapsing-forms of multiple sclerosis. The earn-out also includes an indirect interest in sales of FUMADERM, a therapeutic approved in Germany for the treatment of moderate to severe plaque psoriasis.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
15:35 EDTBIIBNotable companies reporting before tomorrow's open
Subscribe for More Information
06:54 EDTBIIBBiogen October weekly volatility elevated into Q3 and outlook
Subscribe for More Information
October 20, 2014
07:32 EDTBIIBCubist names Perez CEO to succeed Bonney
Subscribe for More Information
October 14, 2014
11:23 EDTBIIBBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use